Delvin Formulations Profile
Key Indicators
- Authorised Capital ₹ 3.25 Cr
- Paid Up Capital ₹ 2.28 Cr
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 27.37 Cr
- Revenue Growth 25.51%
- Profit Growth 67.94%
- Ebitda 25.74%
- Net Worth 100.78%
- Total Assets 5.90%
About Delvin Formulations
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100TN2009PTC072376
-
Company No.
072376
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Delvin Formulations Private Limited offer?
Delvin Formulations Private Limited offers a wide range of products and services, including Health Conditions, Stomach Care, Respiratory Care, Cold & Cough.
Who are the key members and board of directors at Delvin Formulations?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanmugam Muthusamy
|
Director | 24-Jul-2009 | Current |
Jaganathan Jayaseelan
|
Director | 24-Jul-2009 | Current |
|
Bernice Sugirtha
|
Director | 14-Dec-2020 | Current |
|
Ayyavu Rajavel
|
Alternate Director | 13-Aug-2009 | Current |
Financial Performance of Delvin Formulations.
Delvin Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.51% increase. The company also saw a substantial improvement in profitability, with a 67.94% increase in profit. The company's net worth Soared by an impressive increase of 100.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delvin Formulations?
In 2023, Delvin Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Saimirra Innopharm Private LimitedJaganathan Jayaseelan, Bernice Sugirtha and 2 more are mutual person
-
Hibrow Healthcare Private LimitedJaganathan Jayaseelan is a mutual person
-
Inventz Life Sciences Private LimitedJaganathan Jayaseelan is a mutual person
-
Delvin Surgicals Private LimitedJaganathan Jayaseelan and Ayyavu Rajavel are mutual person
-
Lifespan Wellness Private LimitedJaganathan Jayaseelan is a mutual person
-
Nuray Chemicals Private LimitedJaganathan Jayaseelan, Ayyavu Rajavel and 1 more are mutual person
Charges (Loans)
₹0
₹27.37 Cr
Charges Breakdown by Lending Institutions
- Others : 11.91 Cr
- Hdfc Bank Limited : 11.45 Cr
- State Bank Of India : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2022 | Others | ₹10.44 Cr | Satisfied |
| 20 May 2019 | Others | ₹0.09 M | Satisfied |
| 14 Feb 2019 | Others | ₹2.35 M | Satisfied |
| 01 Jun 2018 | Others | ₹2.31 M | Satisfied |
| 30 Jan 2017 | Hdfc Bank Limited | ₹11.45 Cr | Satisfied |
How Many Employees Work at Delvin Formulations?
Delvin Formulations has a workforce of 219 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delvin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delvin Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.